Immuron (IMRN) Finished Goods (2017 - 2020)

Immuron (IMRN) recorded quarterly Finished Goods of $574084.0 in Q4 2020, up 28.79% quarter-over-quarter from $445760.7 in Q2 2020.

Immuron (IMRN) Finished Goods (2017 - 2020) Analysis & Trends

Immuron's Finished Goods history runs 4 years deep, the most recent figure standing at $574084.0 for Q4 2020.

  • In Q4 2020, Finished Goods changed N/A year-over-year to $574084.0; the TTM figure through Dec 2020 stood at $574084.0 (changed N/A YoY), while the FY2020 annual figure was $574084.0, changed N/A from the prior year.
  • Finished Goods was $574084.0 for Q4 2020 at Immuron, up from $445760.7 in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $574084.0 in Q4 2020 to a low of $88383.5 in Q2 2019.
  • Historically, Finished Goods has averaged $315581.6 across 4 years, with a median of $268541.2 in 2017.
  • The sharpest annual moves came in 2019 and 2020: Finished Goods sank 56.06% in 2019, then soared 404.35% in 2020.
  • A 4-year view of Finished Goods shows it stood at $268541.2 in 2017, then declined by 25.1% to $201138.7 in 2018, then tumbled by 56.06% to $88383.5 in 2019, then soared by 549.54% to $574084.0 in 2020.
  • The last three Finished Goods figures came in at $574084.0 (Q4 2020), $445760.7 (Q2 2020), and $88383.5 (Q2 2019), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Immuron 921.61 Mn 921.58 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2020 574,084.00
Jun 30, 2020 445,760.74
Jun 30, 2019 88,383.49
Jun 30, 2018 201,138.65
Jun 30, 2017 268,541.17